KDM2A and neoplasm: Furthermore, knockdown of KDM2A abolished the promotion of breast tumor growth by CAFs in vivo, reduced PD-L1 expression in the stroma, and inhibited NOTCH signaling, which can interfere with tumor angiogenesis [38].